Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sihuan Pharmaceutical Holdings Group Ltd (460) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8041
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and anti-infectives. Its cardio-cerebral vascular drug products comprise aoliankang, yeduojia, yuanzhijiu, oudimei, yimaining, qingtong, qu’ao, chuanqing, aogan and kelinao and anjieli. Sihuan Pharmaceutical offers other drugs such as luoanming, pojia, zhuo’ao and bi’ao and ren’ao. It works in collaboration with other pharmaceutical companies. The company sells its products through its distribution to network hospitals and medical institutions in Zhejiang, Guangdong and Henan. Sihuan Pharmaceutical is headquartered in Beijing, China.

Sihuan Pharmaceutical Holdings Group Ltd (460) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sihuan Pharmaceutical Holdings Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Jilin Sihuan To Acquire Technology Of Pidotimod Injection From Guangzhou Boji Pharma 13
Venture Financing 14
KBP BioSciences Raises USD76 Million in Series A Financing 14
Partnerships 16
Sihuan Pharma Enters into Distribution Agreement with Shandong Buchang Pharma 16
Sihuan Pharma Enters into Agreement with RaQualia Pharma 17
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 18
Covance Enters into Co-Development Agreement with Sihuan Pharma 19
Sihuan Pharma Forms Joint Venture with MSPEA and Euromax 20
Sihuan Enters into Co-Development Agreement with Academy of Military Medical Sciences 21
Sihuan Pharma Enters into Co-Development Agreement with Academy of Military Medical Sciences 22
to-BBB Enters Into R&D Agreement With Sun Moral International 23
Licensing Agreements 24
NeuroVive Pharma Enters Into Licensing Agreement With Sihuan Pharma For CicloMulsion And NeuroStat 24
Equity Offering 26
Sihuan Pharma Rumored For Public Offering Of Shares For US$147 Million 26
Acquisition 27
Sihuan Pharma to Acquire 19.99% Stake in Pharmadax 27
Sihuan Pharma Acquires Ambest Pharma 28
Sihuan Pharma to Acquire 70.7% Stake in Beijing Boren Hospital for USD14.6 million 29
Morgan Stanley Private Equity Asia To Divest Stake In Sihuan Pharma For Upto US$146.4 Million 30
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 31
Sihuan Pharmaceutical Holdings Group Ltd – Key Competitors 32
Sihuan Pharmaceutical Holdings Group Ltd – Key Employees 33
Sihuan Pharmaceutical Holdings Group Ltd – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Strategy And Business Planning 36
Aug 15, 2017: Sihuan Pharmaceutical: Voluntary Announcement Establishment of United States Research and Development Centre 36
Financial Announcements 37
Aug 27, 2018: Sihuan Pharmaceutical Holdings: Announcement of interim results for the six months ended 30 June 2018 37
Aug 21, 2017: Sihuan Pharmaceutical Announces 2017 Interim Results Focused in Low-End Markets and Strengthened Product Brand Building 38
Mar 29, 2017: Sihuan Pharmaceutical Announces 2016 Annual Results 40
Mar 28, 2017: Sihuan Pharmaceutical Holdings Group: Announcement Of Annual Results For The Year Ended 31 December 2016 42
Corporate Communications 43
Apr 20, 2018: Sihuan Pharmaceutical Holdings Group: Resignation and appointment of directors 43
Dec 14, 2017: Sihuan Pharmaceutical Holdings Group: Resignation and Appointment of Directors and Changes in Composition of Board Committees 44
Product News 45
09/10/2018: Sihuan Pharmaceutical’s self-developed rapid-acting insulin analogue Insulin Aspart granted approval for Clinical Trial 45
09/06/2018: Sihuan Pharmaceutical long-acting Insulin Degludec granted approval for clinical trials 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sihuan Pharmaceutical Holdings Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Sihuan Pharmaceutical Holdings Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Jilin Sihuan To Acquire Technology Of Pidotimod Injection From Guangzhou Boji Pharma 13
KBP BioSciences Raises USD76 Million in Series A Financing 14
Sihuan Pharma Enters into Distribution Agreement with Shandong Buchang Pharma 16
Sihuan Pharma Enters into Agreement with RaQualia Pharma 17
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 18
Covance Enters into Co-Development Agreement with Sihuan Pharma 19
Sihuan Pharma Forms Joint Venture with MSPEA and Euromax 20
Sihuan Enters into Co-Development Agreement with Academy of Military Medical Sciences 21
Sihuan Pharma Enters into Co-Development Agreement with Academy of Military Medical Sciences 22
to-BBB Enters Into R&D Agreement With Sun Moral International 23
NeuroVive Pharma Enters Into Licensing Agreement With Sihuan Pharma For CicloMulsion And NeuroStat 24
Sihuan Pharma Rumored For Public Offering Of Shares For US$147 Million 26
Sihuan Pharma to Acquire 19.99% Stake in Pharmadax 27
Sihuan Pharma Acquires Ambest Pharma 28
Sihuan Pharma to Acquire 70.7% Stake in Beijing Boren Hospital for USD14.6 million 29
Morgan Stanley Private Equity Asia To Divest Stake In Sihuan Pharma For Upto US$146.4 Million 30
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 31
Sihuan Pharmaceutical Holdings Group Ltd, Key Competitors 32
Sihuan Pharmaceutical Holdings Group Ltd, Key Employees 33
Sihuan Pharmaceutical Holdings Group Ltd, Subsidiaries 34

List of Figures
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sihuan Pharmaceutical Holdings Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sihuan Pharmaceutical Holdings Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NXT Energy Solutions Inc (SFD):企業の財務・戦略的SWOT分析
    Summary NXT Energy Solutions Inc (NXT Energy), formerly Energy Exploration Technologies Inc is an oilfield service company that offers geophysical services to the upstream oil and gas industry. The company provides Stress Field Detection (SFD) a patent pending gravity-based instrument that provides …
  • Wiener Osiguranje Vienna Insurance Group d.d.:企業の戦略的SWOT分析
    Wiener Osiguranje Vienna Insurance Group d.d. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Johnson Matthey PLC:企業の戦略・SWOT・財務情報
    Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report Summary Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dai-ichi Life Holdings, Inc.:企業の戦略・SWOT・財務分析
    Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Orange Belgium (OBEL):企業の戦略的SWOT分析
    Orange Belgium (OBEL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • Atmos Energy Corporation (ATO)-石油・ガス分野:企業M&A・提携分析
    Summary Atmos Energy Corporation (Atmos Energy) is a natural gas distribution utility. It operates in the regulated natural gas distribution and pipeline businesses, and other nonregulated natural gas businesses. The company delivers natural gas through regulated sales and transportation arrangement …
  • Siemens AG (SIE):企業の財務・戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers faci …
  • China Singyes Solar Technologies Holdings Limited (750):企業の財務・戦略的SWOT分析
    China Singyes Solar Technologies Holdings Limited (750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Eastman Kodak Company (KODK):企業の財務・戦略的SWOT分析
    Eastman Kodak Company (KODK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • Water Intelligence PLC (WATR):企業の財務・戦略的SWOT分析
    Summary Water Intelligence plc (Water Intelligence) formerly Qonnectis Plc, is a clean technology company that offers environmental and technology services. The company offers services such as finding, detecting, and remediating water leaks services. It monitors and protects water infrastructure and …
  • Eskom Uganda Ltd:企業の戦略的SWOT分析
    Eskom Uganda Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Air New Zealand Limited:企業の戦略・SWOT・財務情報
    Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a developer and supplier of pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas, which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolics. It …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆